Cancer Genetics tests in Dubai & UAE

Compare available Cancer Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

700.00–6,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Cancer Genetics test prices

Showing 1–15 of 59 matching tests.

Cancer Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1881 1p & 19q Test This diagnostic test evaluates for the co-deletion of chromosome arms 1p and 19q in glioma tissue samples.	Formalin-fixed paraffin-embedded (FFPE) tumour tissue block or 10 unstained slides	7–8 working days	1,600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Co-deletion of chromosome arms 1p and 19q"] Parameters [] Preparation ["No fasting required", "A tumour tissue sample obtained via biopsy is needed", "A valid doctor’s prescription is required"] Indications ["Diagnosis and classification of glioma, particularly oligodendroglioma", "Guiding personalized treatment decisions", "Predicting chemotherapy response"] Measurement technique Confirm with laboratory Codes LOINC: 49296-6 ICD-10: C71.9 Clinical summary This diagnostic test evaluates for the co-deletion of chromosome arms 1p and 19q in glioma tissue samples.
TEST-2104 AKT1 Gene Cowden Syndrome Type 6 Genetic Test This genetic test identifies pathogenic germline variants in the AKT1 gene associated with an increased risk of hereditary cancers, particularly Cowden syndrome type 6.	Peripheral whole blood (DNA FTA card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic germline variants in the AKT1 gene", "Copy Number Variants (CNVs) within the AKT1 gene"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling session required before sample collection"] Indications ["Individuals with a personal or family history suggestive of Cowden syndrome", "Risk assessment for hereditary breast, thyroid, or endometrial cancer predisposition"] Measurement technique Confirm with laboratory Codes LOINC: 96504-5 ICD-10: Q85.8 Clinical summary This genetic test identifies pathogenic germline variants in the AKT1 gene associated with an increased risk of hereditary cancers, particularly Cowden syndrome type 6.
TEST-2506 ALK Gene (Neuroblastoma Type 3, Familial) Susceptibility NGS Test This test evaluates the ALK gene for hereditary mutations associated with familial neuroblastoma type 3.	Whole Blood, Extracted DNA, or Fingerpick FTA Card	12 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALK gene mutations", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["Genetic counselling required prior to testing"] Indications ["Families with early-onset tumors", "Multiple affected relatives", "Known ALK-related syndromes", "Pre-test genetic counselling"] Measurement technique Confirm with laboratory Codes LOINC: 74057-6 ICD-10: C74.91, Z80.6 Clinical summary This test evaluates the ALK gene for hereditary mutations associated with familial neuroblastoma type 3.
TEST-1870 ALK/EML4 (NSCLC) Gene Rearrangement Test This test detects the presence of ALK/EML4 gene rearrangements in tumor tissue using FISH technology.	Formalin-Fixed Paraffin-Embedded (FFPE) Tumor Tissue Block or Unstained Slides	4–5 Working Days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ALK gene rearrangements", "EML4 gene rearrangements", "Fusion events"] Parameters [] Preparation ["No specific fasting or dietary preparation required", "Valid doctor's prescription is mandatory"] Indications ["Diagnosis of non-small cell lung carcinoma (NSCLC)", "Guidance for targeted therapy selection in NSCLC"] Measurement technique Confirm with laboratory Codes LOINC: 62458-1 ICD-10: C34.9 Clinical summary This test detects the presence of ALK/EML4 gene rearrangements in tumor tissue using FISH technology.
TEST-2093 APC Gene (Familial Adenomatous Polyposis Coli) Genetic Test This genetic test detects pathogenic variants in the APC gene associated with Familial Adenomatous Polyposis (FAP).	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the APC gene", "Point mutations", "Small insertions/deletions", "Large rearrangements (copy number variants)"] Parameters [] Preparation ["No fasting required", "No medication changes required"] Indications ["Diagnosis of Familial Adenomatous Polyposis (FAP)", "Risk assessment for individuals with a family history of FAP", "Pre-symptomatic testing in at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: D12.6, Z15.04 Clinical summary This genetic test detects pathogenic variants in the APC gene associated with Familial Adenomatous Polyposis (FAP).
TEST-1885 BAP1 Tumor Predisposition Syndrome Genetic Test This genetic test detects germline mutations in the BAP1 gene associated with an increased risk of multiple hereditary cancer syndromes.	Peripheral Whole Blood (also acceptable: dried DNA FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BAP1 gene mutations", "Germline genetic variants"] Parameters [] Preparation ["No specific fasting required.", "Inform your physician about any medications you are taking."] Indications ["Individuals with a personal or family history of uveal melanoma, malignant mesothelioma, cutaneous melanoma, or renal cell carcinoma.", "Individuals with a known familial BAP1 mutation."] Measurement technique Confirm with laboratory Codes LOINC: 97656-5 ICD-10: Z15.09 Clinical summary This genetic test detects germline mutations in the BAP1 gene associated with an increased risk of multiple hereditary cancer syndromes.
TEST-2151 BARD1 Gene Breast Cancer Susceptibility Genetic Test This genetic test evaluates for germline mutations within the BARD1 gene, a tumour suppressor associated with hereditary breast cancer susceptibility.	Whole Blood (Peripheral)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the BARD1 gene"] Parameters [] Preparation [] Indications ["Personal or family history of breast cancer", "Assessment of hereditary cancer susceptibility"] Measurement technique Confirm with laboratory Codes LOINC: 91156-2 ICD-10: Z15.01 Clinical summary This genetic test evaluates for germline mutations within the BARD1 gene, a tumour suppressor associated with hereditary breast cancer susceptibility.
TEST-2131 BRAF Gene Exon 15 Sequencing (Genetic Test) This test identifies activating mutations in the BRAF gene, specifically within exon 15, using Next-Generation Sequencing.	Peripheral Whole Blood (EDTA) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["BRAF gene mutations", "V600E mutation"] Parameters [] Preparation ["No fasting required", "No medication changes needed"] Indications ["Melanoma", "Colorectal cancer", "Thyroid cancer"] Measurement technique Confirm with laboratory Codes LOINC: 49590-1 ICD-10: C43.9 Clinical summary This test identifies activating mutations in the BRAF gene, specifically within exon 15, using Next-Generation Sequencing.
TEST-2138 CALR Exon 9 Mutation Analysis (NGS) Test This test detects somatic insertions and deletions within the CALR exon 9 region using Next-Generation Sequencing (NGS). It is used for the diagnosis and risk stratification of Phi...	Whole Blood (Peripheral)	10–15 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic insertions/deletions in CALR exon 9", "Variant Allele Frequency (VAF)"] Parameters [] Preparation ["No fasting required", "Stay well-hydrated", "Provide clinical history, medication list, and previous reports"] Indications ["Diagnosis of Philadelphia-negative MPNs (Essential Thrombocythemia, Primary Myelofibrosis)", "Prognostic stratification in MPNs", "Detection of CALR mutations when JAK2 and MPL are negative"] Measurement technique Confirm with laboratory Codes LOINC: 94477-5 ICD-10: D47.3, D47.4 Clinical summary This test detects somatic insertions and deletions within the CALR exon 9 region using Next-Generation Sequencing (NGS). It is used for the diagnosis and risk stratification of Philadelphia-negative myeloproliferative neoplasms (MPNs).
TEST-1744 CALR Mutation Analysis (Exon 9) Test This test detects mutations (insertions/deletions) in exon 9 of the CALR gene using Sanger sequencing.	Peripheral Whole Blood (EDTA)	7–8 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CALR gene exon 9 insertions/deletions"] Parameters [] Preparation [] Indications ["Diagnosis of essential thrombocythemia", "Diagnosis of primary myelofibrosis", "Risk stratification in myeloproliferative neoplasms"] Measurement technique Confirm with laboratory Codes LOINC: 94758-5 ICD-10: D47.3, D47.1 Clinical summary This test detects mutations (insertions/deletions) in exon 9 of the CALR gene using Sanger sequencing.
TEST-2113 CCND1 Gene Hereditary Colorectal Cancer Susceptibility Genetic Test This genetic test evaluates the CCND1 gene for mutations that increase the risk of developing hereditary colorectal cancer.	Peripheral Whole Blood or FTA Card (Dried Blood Spot)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCND1 gene mutations", "Germline genetic variants"] Parameters [] Preparation [] Indications ["Family history of colorectal cancer", "Early-onset colorectal cancer", "Multiple primary cancers"] Measurement technique Confirm with laboratory Codes LOINC: 78999-1 ICD-10: Z15.09 Clinical summary This genetic test evaluates the CCND1 gene for mutations that increase the risk of developing hereditary colorectal cancer.
TEST-2011 CDK4 Gene Melanoma (Familial Cutaneous Malignant) Genetic Test This genetic test evaluates for inherited mutations in the CDK4 gene, which are associated with an increased risk of familial cutaneous malignant melanoma.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDK4 gene mutations", "Inherited genetic predisposition to melanoma"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "Signed informed consent is required"] Indications ["Individuals with a personal or family history suggestive of familial cutaneous malignant melanoma", "Risk assessment for melanoma"] Measurement technique Confirm with laboratory Codes LOINC: 21636-7 ICD-10: Z15.09 Clinical summary This genetic test evaluates for inherited mutations in the CDK4 gene, which are associated with an increased risk of familial cutaneous malignant melanoma.
TEST-1999 CDKN2A Gene Melanoma, Cutaneous Malignant, Familial Genetic Test This test evaluates the CDKN2A gene for inherited mutations associated with an increased risk of familial melanoma.	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CDKN2A gene mutations", "Point mutations", "Small indels", "Copy number variants (deletions/duplications)"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Individuals with a family history of melanoma", "Individuals with multiple atypical moles", "Assessment of risk for FAMMM syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21658-0 ICD-10: Z15.01 Clinical summary This test evaluates the CDKN2A gene for inherited mutations associated with an increased risk of familial melanoma.
TEST-1660 Chromosome 11q Deletion (ATM) FISH Test This diagnostic test evaluates for the presence of a deletion in the ATM gene locus on chromosome 11q22.3 using Fluorescence In-Situ Hybridization (FISH).	Bone marrow aspirate or peripheral blood	3–4 business days	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ATM gene locus deletion", "Chromosome 11q22.3 region"] Parameters [] Preparation [] Indications ["Risk stratification in Chronic Lymphocytic Leukemia (CLL)", "Risk stratification in Multiple Myeloma (MM)", "Guiding targeted therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 53929-6 ICD-10: C91.1, C90.0 Clinical summary This diagnostic test evaluates for the presence of a deletion in the ATM gene locus on chromosome 11q22.3 using Fluorescence In-Situ Hybridization (FISH).
TEST-1923 DICER1 Gene Pleuropulmonary Blastoma Genetic Test This test evaluates for germline mutations in the DICER1 gene associated with hereditary predisposition to pleuropulmonary blastoma and DICER1 syndrome.	Whole Blood EDTA, Extracted DNA, FTA Card finger-prick	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline DICER1 gene mutations", "Single-nucleotide variants", "Small insertions and deletions", "Copy-number alterations"] Parameters [] Preparation ["No special dietary preparation or medication changes are required", "Inform laboratory and genetic counselor about current medications, supplements, or recent blood transfusions"] Indications ["Personal or family history suggestive of DICER1 syndrome", "Suspicion of inherited DICER1 pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: Z15.09 Clinical summary This test evaluates for germline mutations in the DICER1 gene associated with hereditary predisposition to pleuropulmonary blastoma and DICER1 syndrome.

Category overview

Cancer Genetics: overview

Empowering yourself with a deep understanding of your family’s oncological history is the most effective way to protect your future wellness. As a core pillar of our advanced Molecular Genetics department, comprehensive Cancer Genetics screening provides an in-depth evaluation of the complex hereditary pathways linked to various cancer syndromes. By leveraging cutting-edge genomic technology, this expansive screening delivers the critical clarity required to assess inherited risks, safely guiding customized oncology oversight, specialized prophylactic strategies, and informed family planning. Consistently ranked among the best diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic precision, and prompt, reliable turnaround times. Prioritize your preventative health—book your cancer genetics testing in UAE, arrange a comfortable home sample collection, or consult our specialized genetic counselors.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.